Total Payments
$20,082
2024 Payments
$1,493
Companies
46
Transactions
614
Medicare Patients
6,240
Medicare Billing
$753,116
Payment Breakdown by Category
Food & Beverage$11,822 (58.9%)
Other$5,160 (25.7%)
Consulting$1,580 (7.9%)
Travel$1,389 (6.9%)
Education$130.93 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,822 | 588 | 58.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,160 | 8 | 25.7% |
| Consulting Fee | $1,580 | 4 | 7.9% |
| Travel and Lodging | $1,389 | 7 | 6.9% |
| Education | $130.93 | 7 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $6,343 | 55 | $0 (2020) |
| ABBVIE INC. | $2,307 | 128 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,702 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,174 | 77 | $0 (2024) |
| Janssen Biotech, Inc. | $1,165 | 57 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $699.47 | 8 | $0 (2017) |
| QOL Medical, LLC | $697.34 | 32 | $0 (2024) |
| Gilead Sciences, Inc. | $676.07 | 15 | $0 (2022) |
| Covidien LP | $509.72 | 20 | $0 (2019) |
| IRONWOOD PHARMACEUTICALS, INC | $466.85 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,493 | 77 | ABBVIE INC. ($438.40) |
| 2023 | $1,699 | 90 | ABBVIE INC. ($436.41) |
| 2022 | $1,621 | 77 | ABBVIE INC. ($450.12) |
| 2021 | $1,089 | 72 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($297.40) |
| 2020 | $1,382 | 49 | AbbVie Inc. ($394.69) |
| 2019 | $1,663 | 65 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($419.49) |
| 2018 | $3,728 | 91 | Allergan Inc. ($1,519) |
| 2017 | $7,407 | 93 | Allergan Inc. ($4,534) |
All Payment Transactions
614 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $70.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/17/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,321 | 1,639 | $769,504 | $173,720 |
| 2022 | 19 | 1,483 | 1,974 | $916,586 | $188,514 |
| 2021 | 23 | 1,720 | 2,230 | $1.0M | $205,088 |
| 2020 | 20 | 1,716 | 1,896 | $1.1M | $185,794 |
Total Patients
6,240
Total Services
7,739
Medicare Billing
$753,116
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 220 | 224 | $271,488 | $42,948 | 15.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 198 | 221 | $149,396 | $20,958 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 199 | $26,666 | $16,556 | 62.1% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 31 | 86 | $27,262 | $16,128 | 59.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 107 | 108 | $58,968 | $12,351 | 20.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 112 | 116 | $71,456 | $9,217 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 164 | $14,760 | $8,967 | 60.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 51 | 51 | $10,812 | $8,729 | 80.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 44 | 44 | $9,460 | $7,542 | 79.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 161 | $16,744 | $7,229 | 43.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $42,856 | $5,256 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $9,196 | $4,803 | 52.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 21 | $15,162 | $3,120 | 20.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $23,540 | $3,009 | 12.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $7,735 | $1,800 | 23.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 16 | $7,472 | $1,764 | 23.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $3,492 | $1,678 | 48.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 37 | $2,109 | $1,261 | 59.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 30 | $450.00 | $244.38 | 54.3% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 18 | 20 | $480.00 | $159.60 | 33.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 208 | 210 | $254,520 | $37,425 | 14.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 248 | 285 | $192,660 | $26,741 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 289 | $38,726 | $24,626 | 63.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 33 | 91 | $28,847 | $17,656 | 61.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 136 | 137 | $133,438 | $15,955 | 12.0% |
About Dr. Stephen Keith, MD
Dr. Stephen Keith, MD is a Gastroenterology healthcare provider based in Mccomb, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457332066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Keith, MD has received a total of $20,082 in payments from pharmaceutical and medical device companies, with $1,493 received in 2024. These payments were reported across 614 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($11,822).
As a Medicare-enrolled provider, Keith has provided services to 6,240 Medicare beneficiaries, totaling 7,739 services with total Medicare billing of $753,116. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Mccomb, MS
- Active Since 11/10/2005
- Last Updated 01/06/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1457332066
Products in Payments
- LINZESS (Drug) $6,428
- Amitiza (Drug) $1,049
- STELARA (Biological) $916.60
- XIFAXAN (Drug) $740.11
- GENERAL - BILIARY DEVICES (Device) $568.18
- Entyvio (Biological) $540.00
- HUMIRA (Biological) $516.20
- Barrx (Device) $509.72
- Sucraid (Drug) $488.25
- Epclusa (Drug) $461.36
- ZEPOSIA (Drug) $427.74
- VIBERZI (Drug) $412.68
- GATTEX (Drug) $367.00
- SKYRIZI (Biological) $363.97
- Linzess (Drug) $317.63
- CREON (Drug) $296.09
- IBSRELA (Drug) $284.92
- REMICADE (Biological) $269.95
- DIFICID (Drug) $260.35
- RINVOQ (Biological) $233.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.